The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Selective inhibitors of picornavirus replication
Abstract
Picornaviruses cover a large family of pathogens that have a major impact on human but also on veterinary health. Although most infections in man subside mildly or asymptomatically, picornaviruses can also be responsible for severe, potentially life‐threatening disease. To date, no therapy has been approved for the treatment of picornavirus infections. However, efforts to develop an antiviral that is effective in treating picornavirus‐associated diseases are ongoing. In 2007, Schering‐Plough, under license of ViroPharma, completed a phase II clinical trial with Pleconaril, a drug that was originally rejected by the FDA after a New Drug Application in 2001. Rupintrivir, a rhinovirus protease inhibitor developed at Pfizer, reached clinical trials but was recently halted from further development. Finally, Biota's HRV drug BTA‐798 is scheduled for phase II trials in 2008. Several key steps in the picornaviral replication cycle, involving structural as well as non‐structural proteins, have been identified as valuable targets for inhibition. The current review aims to highlight the most important developments during the past decades in the search for antivirals against picornaviruses. © 2008 Wiley Periodicals, Inc. Med Res Rev, 28, No. 6, 823–884, 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial activity of flavonoids
Cushnie, T. P. T., & Lamb, A. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.09.002 · Cited by 3,195
Grubman, M. J., & Baxt, B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.465-493.2004 · Cited by 1,840
Structure of a human common cold virus and functional relationship to other picornaviruses
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., Hecht, H.-J., Johnson, J. E., Kamer, G., Luo, M., Mosser, A. G., et al. (1985) · Nature · doi:10.1038/317145a0 · Cited by 1,426
Primary structure, gene organization and polypeptide expression of poliovirus RNA
Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., van der Werf, S., et al. (1981) · Nature · doi:10.1038/291547a0 · Cited by 914
Picornaviridae : the viruses and their replication
Racaniello, V. R. (2001) · Medical Entomology and Zoology · Cited by 884
Donnelly, M. L. L., Luke, G., Mehrotra, A., Li, X., Hughes, L. E., Gani, D., & Ryan, M. D. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1013 · Cited by 798
The viruses and their replication
Lindenbach, B. D. (2007) · Medical Entomology and Zoology · Cited by 553
Donnelly, M. L. L., Hughes, L. E., Luke, G., Mendoza, H., ten Dam, E., Gani, D., & Ryan, M. D. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-5-1027 · Cited by 534
Switch from translation to RNA replication in a positive-stranded RNA virus
Gamarnik, A. V., & Andino, R. (1998) · Genes & Development · doi:10.1101/gad.12.15.2293 · Cited by 508
SLEE, E. A., ZHU, H., CHOW, S. C., MacFARLANE, M., NICHOLSON, D. W., & COHEN, G. M. (1996) · Biochemical Journal · doi:10.1042/bj3150021 · Cited by 496
Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA.
Andino, R., Rieckhof, G. E., Achacoso, P. L., & Baltimore, D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06032.x · Cited by 494
A functional ribonucleoprotein complex forms around the 5′ end of poliovirus RNA
Andino, R., Rieckhof, G. E., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90170-j · Cited by 494
The Site of Attachment in Human Rhinovirus 14 for Antiviral Agents That Inhibit Uncoating
Smith, T. J., Kremer, M. J., Luo, M., Vriend, G., Arnold, E., Kamer, G., Rossmann, M. G., McKinlay, M. A., Diana, G. D., & Otto, M. J. (1986) · Science · doi:10.1126/science.3018924 · Cited by 455
Molecular Biology Of Picornaviruses
Semler, B. L., & Wimmer, E. (2002) · Cited by 452
Bazan, J. F., & Fletterick, R. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7872 · Cited by 422
Treatment of Potentially Life-Threatening Enterovirus Infections with Pleconaril
Rotbart, H. A., Webster, A. D., & for the Pleconaril Treatment Registry Group (2001) · Clinical Infectious Diseases · doi:10.1086/318452 · Cited by 373
Jackson, T., Ellard, F. M., Ghazaleh, R. A., Brookes, S. M., Blakemore, W. E., Corteyn, A. H., Stuart, D. I., Newman, J. W., & King, A. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5282-5287.1996 · Cited by 371
Activity of Pleconaril against Enteroviruses
Pevear, D. C., Tull, T. M., Seipel, M. E., & Groarke, J. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2109 · Cited by 368
Matthews, D. A., Smith, W. W., Ferre, R. A., Condon, B., Budahazi, G., Slsson, W., Villafranca, J. E., Janson, C. A., McElroy, H. E., Gribskov, C. L., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90059-0 · Cited by 356
One hundred years of poliovirus pathogenesis
Racaniello, V. R. (2006) · Virology · doi:10.1016/j.virol.2005.09.015 · Cited by 322
Devaney, M. A., Vakharia, V. N., Lloyd, R. E., Ehrenfeld, E., & Grubman, M. J. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4407-4409.1988 · Cited by 319
Matthews, D. A., Dragovich, P. S., Webber, S. E., Fuhrman, S. A., Patick, A. K., Zalman, L. S., Hendrickson, T. F., Love, R. A., Prins, T. J., Marakovits, J. T., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11000 · Cited by 318
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
Fry, E. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.543 · Cited by 308
Hayden, F. G., Herrington, D. T., Coats, T. L., Kim, K., Cooper, E. C., Villano, S. A., Liu, S., Hudson, S., Pevear, D. C., Collett, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375069 · Cited by 306
Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases
Allaire, M., Chernaia, M. M., Malcolm, B. A., & James, M. N. G. (1994) · Nature · doi:10.1038/369072a0 · Cited by 306
Berinstein, A., Roivainen, M., Hovi, T., Mason, P. W., & Baxt, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2664-2666.1995 · Cited by 303
Gamarnik, A. V., & Andino, R. (1997) · PubMed · Cited by 301
The Epithelial Integrin αvβ6 Is a Receptor for Foot-and-Mouth Disease Virus
Jackson, T., Sheppard, D., Denyer, M., Blakemore, W. E., & King, A. M. Q. (2000) · Journal of Virology · doi:10.1128/.74.11.4949-4956.2000 · Cited by 300
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment
Shafren, D. R., Bates, R. C., Agrez, M. V., Herd, R. L., Burns, G. F., & Barry, R. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3873-3877.1995 · Cited by 291
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
Bergelson, J. M., Mohanty, J. G., Crowell, R. L., St John, N. F., Lublin, D. M., & Finberg, R. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1903-1906.1995 · Cited by 278
Joachims, M., Van Breugel, P. C., & Lloyd, R. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.718-727.1999 · Cited by 269
The Crystal Structure of Cruzain: A Therapeutic Target for Chagas' Disease
McGrath, M. E., Eakin, A. E., Engel, J. C., McKerrow, J. H., Craik, C. S., & Fletterick, R. J. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.0137 · Cited by 269
RNA-protein interactions in regulation of picornavirus RNA translation
Belsham, G. J., & Sonenberg, N. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.499-511.1996 · Cited by 266
Isolation of Cytopathic Small Round Viruses with BS-C-l Cells from Patients with Gastroenteritis
Yamashita, T., Kobayashi, S., Sakac, K., Nakata, S., Chiba, S., Ishihara, Y., & Isomura, S. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.5.954 · Cited by 263
Yamashita, T., Sakae, K., Tsuzuki, H., Suzuki, Y., Ishikawa, N., Takeda, N., Miyamura, T., & Yamazaki, S. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8408-8412.1998 · Cited by 255
Mason, P. W., Rieder, E., & Baxt, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1932 · Cited by 254
Picornavirus–receptor interactions
Rossmann, M. G., He, Y., & Kuhn, R. J. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02383-1 · Cited by 250
Msn, F. H., & Md, M. (2004) · Cited by 242
Bienz, K., Egger, D., Troxler, M., & Pasamontes, L. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1156-1163.1990 · Cited by 241
Virus-encoded proteinases of the picornavirus super-group.
Ryan, M. D., & Flint, M. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-4-699 · Cited by 237
Gamarnik, A. V., & Andino, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2219-2226.2000 · Cited by 234
Hayden, F. G., Turner, R. B., Gwaltney, J. M., Chi-Burris, K., Gersten, M., Hsyu, P., Patick, A. K., Smith, G. J., & Zalman, L. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3907-3916.2003 · Cited by 231
Cell-penetrating inhibitors of calpain
Mehdi, S. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90058-4 · Cited by 223
In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease
Patick, A. K., Binford, S. L., Brothers, M. A., Jackson, R. L., Ford, C. E., Diem, M. D., Maldonado, F., Dragovich, P. S., Zhou, R., Prins, T. J., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2444 · Cited by 221
Foot-and-Mouth Disease Virus Virulent for Cattle Utilizes the Integrin α v β 3 as Its Receptor
Neff, S., Sá-Carvalho, D., Rieder, E., Mason, P. W., Blystone, S. D., Brown, E. J., & Baxt, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3587-3594.1998 · Cited by 216
Ohlmann, T., Rau, M., Pain, V. M., & Morley, S. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00479.x · Cited by 211
Ledford, R. M., Patel, N. R., Demenczuk, T. M., Watanyar, A., Herbertz, T., Collett, M. S., & Pevear, D. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3663-3674.2004 · Cited by 211
Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.
Cordingley, M. G., Callahan, P. L., Sardana, V. V., Garsky, V. M., & Colonno, R. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38811-8 · Cited by 206
Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor
Kolatkar, P. R., Bella, J., Olson, N. H., Bator, C. M., Baker, T. S., & Rossmann, M. G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6249 · Cited by 206
Functional analysis of the internal translation initiation site of foot-and-mouth disease virus
Kühn, R., Luz, N., & Beck, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4625-4631.1990 · Cited by 201
Eradication versus control for poliomyelitis: an economic analysis
Thompson, K. M., & Tebbens, R. J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60532-7 · Cited by 200
Poliovirus protein 2C has ATPase and GTPase activities.
Rodríguez, P. L., & Carrasco, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53068-4 · Cited by 197
Crystal structure of human rhinovirus serotype 1A (HRV1A)
Kim, S., Smith, T. J., Chapman, M. S., Rossmann, M. G., Pevear, D. C., Dutko, F. J., Felock, P. J., Diana, G. D., & McKinlay, M. A. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90293-3 · Cited by 197
de los Santos, T., de Avila Botton, S., Weiblen, R., & Grubman, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1906-1914.2006 · Cited by 189
Pevear, D. C., Fancher, M. J., Felock, P. J., Rossmann, M. G., Miller, M. S., Diana, G., Treasurywala, A. M., McKinlay, M. A., & Dutko, F. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2002-2007.1989 · Cited by 188
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
Badger, J., Minor, I., Kremer, M. J., Oliveira, M. A., Smith, T. J., Griffith, J. P., Guerin, D. M., Krishnaswamy, S., Luo, M., & Rossmann, M. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3304 · Cited by 185
Poliovirus Protein 3CD Is the Active Protease for Processing of the Precursor Protein P1 in vitro
Jore, J., De Geus, B., Jackson, R. J., Pouwels, P. H., & Enger-Valk, B. E. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-7-1627 · Cited by 184
Pfister, T., & Wimmer, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6992 · Cited by 181
Belsham, G. J., & Brangwyn, J. K. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5389-5395.1990 · Cited by 180
Dragovich, P. S., Prins, T. J., Zhou, R., Webber, S. E., Marakovits, J. T., Fuhrman, S. A., Patick, A. K., Matthews, D. A., Lee, C. A., Ford, C. E., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805384 · Cited by 180
Integrin αvβ1 Is a Receptor for Foot-and-Mouth Disease Virus
Jackson, T., Mould, A. P., Sheppard, D., & King, A. M. Q. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.935-941.2002 · Cited by 180
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug
Fox, M. P., Otto, M. J., & McKinlay, M. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.1.110 · Cited by 179
4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound
Bauer, D. J., Selway, J. W. T., Batchelor, J. F., Tisdale, M., Caldwell, I. C., & Young, D. A. B. (1981) · Nature · doi:10.1038/292369a0 · Cited by 178
Kuyumcu-Martinez, N. M., Van Eden, M. E., Younan, P., & Lloyd, R. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1779-1790.2004 · Cited by 178
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C
Pincus, S. E., Diamond, D. C., Emini, E. A., & Wimmer, E. (1986) · Journal of Virology · doi:10.1128/jvi.57.2.638-646.1986 · Cited by 172
Human parechoviruses?biology and clinical significance
Stanway, G., Joki-Korpela, P., & Hyypi�, T. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200001/02)10:1<57::aid-rmv266>3.0.co;2-h · Cited by 169
Regulation of picornavirus gene expression
Bedard, K. M., & Semler, B. L. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.03.001 · Cited by 167
de Felipe, P., Hughes, L. E., Ryan, M. D., & Brown, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211644200 · Cited by 167
Barton, D. J., & Flanegan, J. B. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8482-8489.1997 · Cited by 166
Spiro indolinone beta-lactams, inhibitors of poliovirus and rhinovlrus 3C-proteinases
Skiles, J. W., & McNeil, D. (1990) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)88543-3 · Cited by 165
Antipicornavirus flavone Ro 09-0179
Ishitsuka, H., Ohsawa, C., Ohiwa, T., Umeda, I., & Suhara, Y. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.4.611 · Cited by 162
The structure of human rhinovirus 16
Oliveira, M., Zhao, R., Lee, W.-M., Kremer, M. J., Minor, I., Rueckert, R. R., Diana, G., Pevear, D. C., Dutko, F. J., McKinlay, M. A., et al. (1993) · Structure · doi:10.1016/0969-2126(93)90008-5 · Cited by 161
Andries, K., Dewindt, B., Snoeks, J., Wouters, L., Moereels, H., Lewi, P. J., & Janssen, P. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1117-1123.1990 · Cited by 160
Cellular Protein Modification by Poliovirus: the Two Faces of Poly(rC)-Binding Protein
Perera, R., Daijogo, S., Walter, B. L., Nguyen, J. H. C., & Semler, B. L. (2007) · Journal of Virology · doi:10.1128/jvi.01013-07 · Cited by 158
Degradation of Nuclear Factor Kappa B during Foot-and-Mouth Disease Virus Infection
Santos, T. D. L., Segundo, F. D.-S., & Grubman, M. J. (2007) · Journal of Virology · doi:10.1128/jvi.01467-07 · Cited by 158
Binford, S. L., Maldonado, F., Brothers, M. A., Weady, P., Zalman, L. S., Meador, J. W., Matthews, D. A., & Patick, A. K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.619-626.2005 · Cited by 155
Tong, L. (2002) · Chemical Reviews · doi:10.1021/cr010184f · Cited by 154
Chau, D., Ji, Y., Zhang, H., Cheung, P., Lim, T. W., Liu, Z., Sall, A., & Yang, D. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0013-0 · Cited by 149
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity
Meyer, N. D., Haemers, A., Mishra, L., Pandey, H. K., Pieters, L. A. C., Berghe, D. A. V., & Vlietinck, A. J. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00106a039 · Cited by 146
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug
McSharry, J. J., Caliguiri, L. A., & Eggers, H. J. (1979) · Virology · doi:10.1016/0042-6822(79)90342-8 · Cited by 145
Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease
Webber, S. E., Tikhe, J. G., Worland, S. T., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960603e · Cited by 144
Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase.
Caselli, A., Camici, G. G., Manao, G., Moneti, G., Pazzagli, L., Cappugi, G., & Ramponi, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31472-2 · Cited by 142
Jackson, T., Clark, S. A., Berryman, S., Burman, A., Cambier, S., Mu, D., Nishimura, S. L., & King, A. M. Q. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4533-4540.2004 · Cited by 142
The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus
Heinz, B. A., & Vance, L. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4189-4197.1995 · Cited by 142
Dragovich, P. S., Prins, T. J., Zhou, R., Brown, E. L., Maldonado, F. C., Fuhrman, S. A., Zalman, L. S., Tuntland, T., Lee, C. A., Patick, A. K., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010469k · Cited by 142
THE GENETICS OF THE PERSISTENT INFECTION AND DEMYELINATING DISEASE CAUSED BY THEILER'S VIRUS
Brahic, M., Bureau, J., & Michiels, T. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121242 · Cited by 141
Hambidge, S. J., & Sarnow, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10272 · Cited by 139
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
ABZUG, M. J., CLOUD, G., BRADLEY, J., SÁNCHEZ, P. J., ROMERO, J., POWELL, D., LEPOW, M., MANI, C., CAPPARELLI, E. V., BLOUNT, S., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000059765.92623.70 · Cited by 138
SPECTRUM AND CHARACTERISTICS OF THE VIRUS INHIBITORY ACTION OF 2-(α-HYDROXYBENZYL)-BENZIMIDAZOLE
Eggers, H. J., & Tamm, I. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.113.4.657 · Cited by 138
Back, S. H., Kim, Y. K., Kim, W. J., Cho, S., Oh, H. R., Kim, J.-E., & Jang, S. K. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2529-2542.2002 · Cited by 138
Patick, A. K., Brothers, M. A., Maldonado, F., Binford, S. L., Maldonado, O., Fuhrman, S. A., Petersen, A., Smith, G. J., Zalman, L. S., Burns‐Naas, L. A., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2267-2275.2005 · Cited by 136
Enterovirus infections: Diagnosis and treatment
Sawyer, M. H. (2002) · Seminars in Pediatric Infectious Diseases · doi:10.1053/spid.2002.29756 · Cited by 133
Petersen, J. F. W., Cherney, M. M., Liebig, H., Skern, T., Kuechler, E., & James, M. N. G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5463 · Cited by 129
Heinz, B. A., Rueckert, R. R., Shepard, D. A., Dutko, F. J., McKinlay, M. A., Fancher, M. J., Rossmann, M. G., Badger, J., & Smith, T. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2476-2485.1989 · Cited by 123
Lentz, K. N., Smith, A. D., Geisler, S. C., Cox, S., Buontempo, P. J., Skelton, A., DeMartino, J., Rozhon, E. J., Schwartz, J. L., GIRIJAVALLABHAN, V. M., et al. (1997) · Structure · doi:10.1016/s0969-2126(97)00249-9 · Cited by 123
Rightsel, W. A., Dice, J. R., McAlpine, R. J., Timm, E. A., McLean, I. W., Dixon, G. J., & Schabel, F. M. (1961) · Science · doi:10.1126/science.134.3478.558 · Cited by 123
Poliovirus 2C region functions during encapsidation of viral RNA
Vance, L. M., Moscufo, N., Chow, M., & Heinz, B. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8759-8765.1997 · Cited by 119
Patick, A. K. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.011 · Cited by 118
In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug
Otto, M. J., Fox, M., Fancher, M. J., Kuhrt, M., Diana, G. D., & McKinlay, M. A. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.6.883 · Cited by 117
TREATMENT OF THE PICORNA VIRUS COMMON COLD BY INHIBITORS OF VIRAL UNCOATING AND ATTACHMENT
McKinlay, M. A., Pevear, D. C., & Rossmann, M. G. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.003223 · Cited by 115
Dragovich, P. S., Prins, T. J., Zhou, R., Johnson, T., Hua, Y., Luu, H. T., Sakata, S. K. L., Brown, E. L., Maldonado, F. C., Tuntland, T., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030166l · Cited by 114
Action of guanidine on the replication of poliovirus RNA
Caliguiri, L. A., & Tamm, I. (1968) · Virology · doi:10.1016/0042-6822(68)90219-5 · Cited by 113
Dragovich, P. S., Webber, S. E., Babine, R. E., Fuhrman, S. A., Patick, A. K., Matthews, D. A., Reich, S., Marakovits, J. T., Prins, T. J., Zhou, R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800696 · Cited by 112
Human rhinovirus 3 at 3.0 å resolution
Zhao, R., Pevear, D. C., Kremer, M. J., Giranda, V. L., Kofron, J. A., Kuhn, R. J., & Rossmann, M. G. (1996) · Structure · doi:10.1016/s0969-2126(96)00128-1 · Cited by 111
Pincus, S. E., & Wimmer, E. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.793-796.1986 · Cited by 109
Structure-activity relationships for inhibition of papain by peptide Michael acceptors
Liu, S., & Hanzlik, R. P. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00084a012 · Cited by 109
Shia, K., Li, W., Chang, C.-M., Hsu, M., Chern, J., Leong, M. K., Tseng, S., Lee, C.-C., Lee, Y., Chen, S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010536a · Cited by 109
Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection
Hayden, F. G., Andries, K., & Janssen, P. A. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.727 · Cited by 108
Si, X., McManus, B. M., Zhang, J., Ji, Y., Cheung, C., Esfandiarei, M., Suarez, A., Morgan, A., & Luo, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8014-8023.2005 · Cited by 108
Diana, G. D., Rudewicz, P. J., Pevear, D. C., Nitz, T. J., Aldous, S. C., Aldous, D., Robinson, D. T., Draper, T. L., Dutko, F. J., Aldi, C., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00008a014 · Cited by 108
Serine and Threonine β-Lactones: A New Class of Hepatitis A Virus 3C Cysteine Proteinase Inhibitors
Lall, M. S., Ramtohul, Y. K., James, M. N. G., et al. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo0109016 · Cited by 108
KAISER, L., CRUMP, C., & HAYDEN, F. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00106-6 · Cited by 107
Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures
Crowther, D., & Melnick, J. L. (1961) · Virology · doi:10.1016/0042-6822(61)90078-2 · Cited by 107
Integrin α v β 6 Is an RGD-Dependent Receptor for Coxsackievirus A9
Williams, Ç. H., Kajander, T., Hyypiä, T., Jackson, T., Sheppard, D., & Stanway, G. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6967-6973.2004 · Cited by 107
Pevear, D. C., Hayden, F. G., Demenczuk, T. M., Barone, L. R., McKinlay, M. A., & Collett, M. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4492-4499.2005 · Cited by 107
Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis
Evans, D. J., & Almond, J. W. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01263-3 · Cited by 105
Intranasal pirodavir (R77,975) treatment of rhinovirus colds
Hayden, F. G., Hipskind, G. J., Woerner, D., Eisen, G., Janssens, M., Janssen, P. A., & Andries, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.290 · Cited by 102
THE ACTIVITY OF ENVIROXIME AGAINST RHINOVIRUS INFECTION IN MAN
PHILLPOTTS, R. J., Delong, D., Wallace, J. G., Jones, R. G., Reed, S. E., & Tyrrell, D. J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92520-4 · Cited by 93
Dragovich, P. S., Webber, S. E., Babine, R. E., Fuhrman, S. A., Patick, A. K., Matthews, D. A., Lee, C. A., Reich, S., Prins, T. J., Marakovits, J. T., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980068d · Cited by 92
Webber, S. E., Okano, K., Little, T. L., Reich, S., Xin, Y., Fuhrman, S. A., Matthews, D. A., Love, R. A., Hendrickson, T. F., Patick, A. K., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980071x · Cited by 89
Tolskaya, E. A., Romanova, L. I., Kolesnikova, M. S., Gmyl, A. P., Gorbalenya, A. E., & Agol, V. I. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90060-4 · Cited by 89
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)
Al‐Nakib, W., Higgins, P. G., Barrow, G. I., Tyrrell, D. A. J., Andries, K., Bussche, G. V., Taylor, N., & Janssen, P. A. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.522 · Cited by 87
Ziegler, E., Borman, A. M., Kirchweger, R., Skern, T., & Kean, K. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3465-3474.1995 · Cited by 85
Hayden, F. G., & Gwaltney, J. M. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.6.892 · Cited by 84
Antiviral Effects of Pyrrolidine Dithiocarbamate on Human Rhinoviruses
Gaudernak, E., Seipelt, J., Triendl, A., Grassauer, A., & Kuechler, E. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6004-6015.2002 · Cited by 84
Genetic reclassification of porcine enteroviruses
Kaku, Y., Sarai, A., & Murakami, Y. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-2-417 · Cited by 83
Specific Inhibition of Viral Ribonucleic Acid Replication by Gliotoxin
Miller, P. A., Kp, M., & Trown, P. W. (1968) · Science · doi:10.1126/science.159.3813.431 · Cited by 83
A Comparison of the Anti-rhinoviral Drug Binding Pocket in HRV14 and HRV1A
Kim, K. H., Willingmann, P., Gong, Z. X., et al. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1137 · Cited by 80
Palmenberg, A. C., Parks, G. D., Hall, D. J., Ingraham, R. H., Seng, T. W., & Pallai, P. V. (1992) · Virology · doi:10.1016/0042-6822(92)90913-a · Cited by 79
Dragovich, P. S., Prins, T. J., Zhou, R., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00008-2 · Cited by 78
Shih, S., Tsai, M.-C., Tseng, S., Won, K.-F., Shia, K., Li, W., Chern, J., Chen, G., Lee, C.-C., Lee, Y., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3523-3529.2004 · Cited by 78
Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation
Ali, I. K., McKendrick, L., Morley, S., & Jackson, R. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4233 · Cited by 78
Hoof, L. V., Berghe, D., Hatfield, G. M., & Vlietinck, A. J. (1984) · PubMed · Cited by 77
SEVERE NEONATAL ENTEROVIRAL HEPATITIS TREATED WITH PLECONARIL
Aradottir, E., Alonso, E. M., & Shulman, S. T. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200104000-00022 · Cited by 77
Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment
Vlasak, M., Goesler, I., & Blaas, D. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.5963-5970.2005 · Cited by 77
Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus
Kleina, L. G., & Grubman, M. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7168-7175.1992 · Cited by 75
Therapeutic activity of enviroxime against rhinovirus infection in volunteers
PHILLPOTTS, R. J., Wallace, J. G., Tyrrell, D. A. J., & Tagart, V. B. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.5.671 · Cited by 75
Cell Recognition and Entry by Rhino- and Enteroviruses
Rossmann, M. G., Bella, J., Kolatkar, P. R., He, Y., Wimmer, E., Kuhn, R. J., & Baker, T. S. (2000) · Virology · doi:10.1006/viro.2000.0258 · Cited by 75
Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C
Baltera, R. F., & Tershak, D. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4441-4444.1989 · Cited by 73
Kuz’min, V. Е., Artemenko, A. G., Muratov, E. N., VOLINECKAYA, I., Makarov, V., Riabova, O., Wutzler, P., & Schmidtke, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0704806 · Cited by 73
Vinylogous amino acid esters: a new class of inactivators for thiol proteases
Hanzlik, R. P., & Thompson, S. A. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00372a001 · Cited by 72
Lanke, K. H. W., Krenn, B. M., Melchers, W. J. G., Seipelt, J., & van Kuppeveld, F. J. M. (2007) · Journal of General Virology · doi:10.1099/vir.0.82634-0 · Cited by 72
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug
Woods, M. G., Diana, G. D., Rogge, M. C., Otto, M. J., Dutko, F. J., & McKinlay, M. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.12.2069 · Cited by 72
Introduction and History of Foot-and-Mouth Disease Virus
Mahy, B. W. J. (2005) · Springer eBooks · doi:10.1007/3-540-27109-0_1 · Cited by 71
Attenuated Virulence of Pleconaril‐Resistant Coxsackievirus B3 Variants
Groarke, J. M., & Pevear, D. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314758 · Cited by 71
Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol
Rodrı́guez, P. L., & Carrasco, L. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1971-1976.1992 · Cited by 69
Antiviral activity of substituted homoisoflavonoids on enteroviruses
Tait, S., Salvati, A. L., Desideri, N., & Fiore, L. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.07.003 · Cited by 69
Hoof, L. V., Berghe, D., Hatfield, G. M., & Vlietinck, A. J. (1984) · Planta Medica · doi:10.1055/s-2007-969786 · Cited by 69
Effect of arildone on modifications of poliovirus in vitro
Caliguiri, L. A., McSharry, J. J., & Lawrence, G. W. (1980) · Virology · doi:10.1016/0042-6822(80)90158-0 · Cited by 68
Dragovich, P. S., Prins, T. J., Zhou, R., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980537b · Cited by 68
In vitro Inhibition of Infectivity of Polio Viruses by Guanidine
Loddo, B., Ferrari, W., Brotzu, G., & Spanedda, A. M. (1962) · Nature · doi:10.1038/193097a0 · Cited by 68
Brown, R. N., Cameron, R., Chalmers, D. K., Hamilton, S., Luttick, A., Krippner, G. Y., McConnell, D. B., Nearn, R. H., Stanislawski, P. C., Tucker, S. P., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.054 · Cited by 68
Controlled trial of enviroxime against natural rhinovirus infections in a community
Miller, F. D., Monto, A. S., Delong, D., Exelby, A., Bryan, E. R., & Srivastava, S. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.1.102 · Cited by 67
Mallia, P., Contoli, M., Caramori, G., Pandit, A., Johnston, S. L., & Papi, A. A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313777 · Cited by 67
The picornaviral 3C proteinases: Cysteine nucleophiles in serine proteinase folds
Malcolm, B. A. (1995) · Protein Science · doi:10.1002/pro.5560040801 · Cited by 66
Barnard, D. L., Hubbard, V. D., SMEE, D. F., Sidwell, R. W., Watson, K. G., Tucker, S. P., & Reece, P. A. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1766-1772.2004 · Cited by 64
Viral protease cleavage of inhibitor of κBα triggers host cell apoptosis
Zaragoza, C., Saura, M., Padalko, E. Y., Lopez-Rivera, E., Lizarbe, T. R., Lamas, S., & Lowenstein, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606019103 · Cited by 63
Turner, R. B. (1998) · Pediatric Annals · doi:10.3928/0090-4481-19981201-06 · Cited by 61
Eggers, H. J., & Tamm, I. (1962) · Virology · doi:10.1016/0042-6822(62)90033-8 · Cited by 61
Molla, A., Hellen, C. U. T., & Wimmer, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4688-4695.1993 · Cited by 60
Pleconaril, a Novel Antipicornaviral Agent
Florea, N. R., Maglio, D., & Nicolau, D. P. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.3.339.32099 · Cited by 60
Kong, J.-S., Venkatraman, S., Furness, K., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980114+ · Cited by 59
Antiviral Therapy for Enteroviruses and Rhinoviruses
Rotbart, H. A. (2000) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020001100402 · Cited by 59
Shimizu, H., Agoh, M., Agoh, Y., Yoshida, H., Yoshii, K., Yoneyama, T., Hagiwara, A., & Miyamura, T. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4146-4154.2000 · Cited by 59
Zautner, A. E., Jahn, B., Hammerschmidt, E., Wutzler, P., & Schmidtke, M. (2006) · Journal of Virology · doi:10.1128/jvi.01988-05 · Cited by 59
Zalman, L. S., Brothers, M. A., Dragovich, P. S., Zhou, R., Prins, T. J., Worland, S. T., & Patick, A. K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1236-1241.2000 · Cited by 59
Purification and partial characterization of poliovirus protease 2A by means of a functional assay
König, H., & Rosenwirth, B. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1243-1250.1988 · Cited by 58
Action of 3-methylquercetin on poliovirus RNA replication
Castrillo, J. L., & Carrasco, L. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3319-3321.1987 · Cited by 58
Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells
Brewer, L. A., Lwamba, H. C. M., Murtaugh, M. P., Palmenberg, A. C., Brown, C., & Njenga, M. K. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11621-11629.2001 · Cited by 58
Rossmann, M. G. (1989) · Viral Immunology · doi:10.1089/vim.1989.2.143 · Cited by 57
Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection
Turner, R. B., Dutko, F. J., Goldstein, N. H., Lockwood, G. F., & Hayden, F. G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.297 · Cited by 57
Kundu, P., Raychaudhuri, S., Tsai, W., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9702-9713.2005 · Cited by 56
Oral efficacy of WIN 51711 in mice infected with human poliovirus
McKinlay, M. A., & Steinberg, B. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.1.30 · Cited by 55
Pincus, S., Rohl, H., & Wimmer, E. (1987) · Virology · doi:10.1016/0042-6822(87)90316-3 · Cited by 55
Zhang, B., Morace, G., Gauss‐Müller, V., & Kusov, Y. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm645 · Cited by 55
Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16
Hadfield, A. T., Diana, G. D., & Rossmann, M. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14730 · Cited by 54
Mosser, A. G., Sgro, J.-Y., & Rueckert, R. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8193-8201.1994 · Cited by 54
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses
Badger, J., Minor, I., Oliveira, M. A., Smith, T. J., & Rossmann, M. G. (1989) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340060102 · Cited by 54
Mosser, A. G., & Rueckert, R. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1246-1254.1993 · Cited by 53
Triantafilou, M., Triantafilou, K., Wilson, K. M. O., et al. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-10-2591 · Cited by 53
Synthesis, Antiviral Activity, and Biological Properties of Vinylacetylene Analogs of Enviroxime
Victor, F., Brown, T. J., Campanale, K. M., Heinz, B. A., Shipley, L. A., Su, K. S. E., Tang, J. C., Vance, L. M., & Spitzer, W. A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960718i · Cited by 53
Saunders, K., & King, A. M. Q. (1982) · Journal of Virology · doi:10.1128/jvi.42.2.389-394.1982 · Cited by 52
Mechanism of Action of Gliotoxin: Elimination of Activity by Sulfhydryl Compounds
Trown, P. W., & Bilello, J. A. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.4.261 · Cited by 52
Saunders, K., King, A. M. Q., McCahon, D., Newman, J. W. I., Slade, W. R., & Forss, S. (1985) · Journal of Virology · doi:10.1128/jvi.56.3.921-929.1985 · Cited by 51
Krenn, B. M., Holzer, B., Gaudernak, E., Triendl, A., van Kuppeveld, F. J. M., & Seipelt, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13892-13899.2005 · Cited by 51
Gelmetti, D., Meroni, A., Brocchi, E., Koenen, F., & Cammarata, G. (2005) · Veterinary Research · doi:10.1051/vetres:2005041 · Cited by 51
Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers
Hsyu, P.-H., Pithavala, Y. K., Gersten, M., Penning, C. A., & Kerr, B. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.392-397.2002 · Cited by 49
Inhibition of poliovirus polymerase by guanidine in vitro
Tershak, D. R. (1982) · Journal of Virology · doi:10.1128/jvi.41.1.313-318.1982 · Cited by 49
Single dose pharmacokinetics of pleconaril in neonates
Kearns, G. L., Bradley, J. S., Jacobs, R. F., Capparelli, E. V., James, L. P., Johnson, K., & ABDELRAHMAN, S. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200009000-00005 · Cited by 49
An Orally Bioavailable Oxime Ether Capsid Binder with Potent Activity against Human Rhinovirus
Watson, K. G., Brown, R. N., Cameron, R., Chalmers, D. K., Hamilton, S., Jin, B., Krippner, G. Y., Luttick, A., McConnell, D. B., Reece, P. A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0202876 · Cited by 49
Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes
Wyde, P. R., Six, H. R., Wilson, S. Z., Gilbert, B. E., & Knight, V. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.890 · Cited by 48
Vrijsen, R., Everaert, L., Hoof, L. M. V., Vlietinck, A. J., Berghe, D. A. V., & Boeyé, A. (1987) · Antiviral Research · doi:10.1016/0166-3542(87)90037-4 · Cited by 48
Bergmann, E. M., Cherney, M. M., McKendrick, J. E., Frormann, S., Luo, C., Malcolm, B. A., Vederas, J. C., & James, M. N. G. (1999) · Virology · doi:10.1006/viro.1999.9968 · Cited by 48
Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase
Deszcz, L., Seipelt, J., Vassilieva, E. V., Roetzer, A., & Kuechler, E. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00069-9 · Cited by 47
Chern, J., Lee, C., Chang, C., Lee, Y., Tai, C., Lin, Y., Shia, K., Lee, C.-Y., & Shih, S. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.084 · Cited by 47
Synthesis and Anti-Rhinovirus Properties of Fluoro-Substituted Flavonoids
Conti, C., Mastromarino, P., Goldoni, P., Portalone, G., & Desideri, N. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600406 · Cited by 47
Harki, D. A., Graci, J. D., Galarraga, J. E., Chain, W. J., Cameron, C. E., & Peterson, B. R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060872x · Cited by 46
Ledford, R. M., Collett, M. S., & Pevear, D. C. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.08.003 · Cited by 45
Carrasco, L. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90040-x · Cited by 45
Cited by
Colunga Biancatelli, R. M. L., Berrill, M., Catravas, J. D., & Marik, P. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01451 · Cited by 512
Mastrangelo, E., Pezzullo, M., De Burghgraeve, T., Kaptein, S., Pastorino, B., Dallmeier, K., de Lamballerie, X., Neyts, J., Hanson, A. M., Frick, D. N., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks147 · Cited by 414
Self-citationThe role of viruses in acute exacerbations of asthma
Jackson, D. J., & Johnston, S. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.021 · Cited by 351
Viral infections in type 1 diabetes mellitus — why the β cells?
Op de Beeck, A., & Eizirik, D. L. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.30 · Cited by 291
The ABCs of Rhinoviruses, Wheezing, and Asthma
Gern, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.02290-09 · Cited by 263
Metadata
- Authors
- De Palma, A. M., Vliegen, I., De Clercq, E., & Neyts, J.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2008-04
- Volume
- 28
- Issue
- 6
- Pages
- 823-884
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2133646471
- Cited by
- 259
- References
- 247
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.